HC Wainwright Has Negative Forecast for FibroGen Q2 Earnings
FibroGen, Inc. (NASDAQ:FGEN – Free Report) – Investment analysts at HC Wainwright reduced their Q2 2025 earnings per share (EPS) estimates for FibroGen in a research note issued on Tuesday, May 13th. HC Wainwright analyst M. Keller now anticipates that the biopharmaceutical company will post earnings of $0.04 per share for the quarter, down from […]
FibroGen, Inc. (NASDAQ:FGEN – Free Report) – Investment analysts at HC Wainwright reduced their Q2 2025 earnings per share (EPS) estimates for FibroGen in a research note issued on Tuesday, May 13th. HC Wainwright analyst M. Keller now anticipates that the biopharmaceutical company will post earnings of $0.04 per share for the quarter, down from […]
